Theranos' board: Plenty of political connections, little relevant expertise

So begins Fortune Editor-at-Large Roger Parloff’s 2014 piece on the board of directors at Theranos, the blood-testing company that was the subject of a deeply reported story in The Wall Street Journal this morning questioning the reliability of its drug tests.

Full Article Here